22nd Century Group, Inc (XXII) by event type
XXII moves most on coverage initiations — a median of -3.45% at 30 minutes across 19 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the XXII overview →
How XXII reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 2,267 of 2,283 | 19 | -3.45% | 11% | -2.73% |
| Rating reiterations 3,513 of 3,522 | 18 | -2.07% | 33% | -1.33% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how XXII usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · XXII overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Eyenovia, Inc. (EYEN) | 266 | -0.95% | 38% |
| Qiagen N.V. Common Shares (QGEN) | 266 | +0.05% | 53% |
| Cellectar Biosciences, Inc. (CLRB) | 265 | +0.27% | 52% |
| EVOTEC AG S/ADR (EVTCY) | 265 | 0.00% | 17% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.